IRCT20210612051545N4招募中1 期
Clinical trial of safety and effectiveness of subcutaneous injection of placenta Growth factors in the treatment of androgenetic alopecia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •Patients with androgenetic alopecia
- •Age 18 to 50 years
- •Norwood-Hamilton grade II to V
排除标准
- •Patients with two or more diagnoses of hair loss
- •Treatment of hair loss in the last 3 months
- •Patients undergoing radiotherapy and chemotherapy
- •Immunosuppressive drugs or corticosteroids during the previous 4 weeks
- •Uncontrolled chronic diseases
- •Coagulopathy or the use of anticoagulants
- •History of autoimmune diseases
- •HBV, HCV and HIV infections
研究者
相似试验
招募中
1 期
Placenta extract in the treatment of androgenetic hair lossIRCT20210612051545N5Tehran University of Medical Sciences30
尚未招募
4 期
This study aims to compare 2 facial plane blocks using local anesthestic drug in providing pain free period in patients undergoing abdominal surgeries under general anesthesiaCTRI/2024/06/069573Dr Priyanka D S
已完成
不适用
The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test)JPRN-UMIN000022129Osaka University Hospital5
已完成
2 期
effect of Sovodak in patients with hepatitis C and HIV-1Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.Acute hepatitis CHuman immunodeficiency virus [HIV] diseaseIRCT20180924041107N1Tabriz University of Medical Sciences22
已完成
不适用
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancercolorectal cancerJPRN-UMIN000001547Tsukuba Cancer Clinical Trial Group400